This project seeks to determine whether polymorphisms in the TP53 and MDM2 genes are responsible for early-onset breast and colon cancer in African Americans. This will be accomplished by cancer exome sequencing of tumors from African Americans and Caucasian Americans with defined combinations of genotypes, and comparing the somatic mutation rates between the groups of patients. We will utilize exome capture and high- throughput paired-end sequencing technologies to identify exonic somatic mutations in 160 tumors representing the four combinations of TP53 Pro/Pro vs Arg/Arg genotypes and MDM2 SNP309 T/T vs G/G genotypes. This will allow correlations to be drawn between the numbers and types of somatic mutations, and race, TP53 genotype, and MDM2 genotype, and it will permit the determination of whether differences in mutation rates between the two races can be attributed to the genetic differences at these two loci. The existence of a cause and effect relationship between genotype and phenotype will be tested by constructing isogenic sets of breast and colon cancer cell lines that represent these four genotype combinations and carefully examining the modified cells for augmented or diminished TP53-dependent cell cycle arrest, apoptosis, or mutation rate.

Public Health Relevance

African Americans are diagnosed with breast and colon cancer at early ages more frequently than are Caucasian Americans, however the reasons are not clear. This work will formally prove whether or not specific DNA sequences, which are more common in African Americans than in Caucasian Americans, can pre- dispose individuals to early onset breast or colon cancer, regardless of their race. If the hypothesis put forth in this proposal is validated, these results will provide the basis for identifying individuals that are at high risk for developing breast or colon cancer, and justify deploying more aggressive screening guidelines for those harboring high-risk DNA sequences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA158428-03
Application #
8704891
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Watson, Joanna M
Project Start
2013-05-16
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Liu, Changlong; Banister, Carolyn E; Weige, Charles C et al. (2018) PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A 115:E5066-E5075
Li, Yuanyuan; Buckhaults, Phillip; Li, Shizhao et al. (2018) Temporal Efficacy of a Sulforaphane-Based Broccoli Sprout Diet in Prevention of Breast Cancer through Modulation of Epigenetic Mechanisms. Cancer Prev Res (Phila) 11:451-464
Banister, Carolyn E; Liu, Changlong; Pirisi, Lucia et al. (2017) Identification and characterization of HPV-independent cervical cancers. Oncotarget 8:13375-13386
Illuzzi, Jennifer L; McNeill, Daniel R; Bastian, Paul et al. (2017) Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes. Environ Mol Mutagen 58:84-98
Oliver, David; Ji, Hao; Liu, Piaomu et al. (2017) Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci Rep 7:43023
Zhang, Xinyan; Li, Yan; Akinyemiju, Tomi et al. (2017) Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach. Genetics 205:89-100
Guo, Huabei; Zhang, Bing; Nairn, Alison V et al. (2017) O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1. J Biol Chem 292:4123-4137
Beasley, Sarah; Buckhaults, Phillip J; Pedigo, Nancy G et al. (2016) Association of FGD1 polymorphisms with early-onset breast cancer. Oncol Lett 12:2071-2077
Miciak, Jessica; Bunz, Fred (2016) Long story short: p53 mediates innate immunity. Biochim Biophys Acta 1865:220-7
Li, Yuanyuan; Buckhaults, Phillip; Cui, Xiangqin et al. (2016) Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals. Epigenomics 8:1019-37

Showing the most recent 10 out of 13 publications